MARC details
| 000 -LEADER |
|---|
| fixed length control field |
13088cam a22004814a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
465378724 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
SUN |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20180803110631.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
091109s2011 moua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2009047493 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323055444 |
| Terms of availability |
(pbk. : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0323055443 |
| Terms of availability |
(pbk. : alk. paper) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)465378724 |
| Canceled/invalid control number |
(OCoLC)432981059 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Language of cataloging |
eng |
| Transcribing agency |
SUNLIB |
| Modifying agency |
BTCTA |
| -- |
NLM |
| -- |
C#P |
| -- |
YDXCP |
| -- |
BWX |
| -- |
UWO |
| -- |
CDX |
| -- |
IG# |
| -- |
EEK |
| -- |
TULIB |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM301 |
| Item number |
.L466 2011 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1/ |
| Item number |
LIL |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lilley,Linda lane |
| 9 (RLIN) |
5753 |
| 110 ## - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Linda lane Lilley |
| 9 (RLIN) |
5754 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Pharmacology and the nursing process / |
| Statement of responsibility, etc. |
Linda Lane Lilley ... [et al.] ; with study skills content by Diane Savoca |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
6th ed |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Maryland Heights, MO : |
| Name of publisher, distributor, etc. |
Mosby, |
| Date of publication, distribution, etc. |
c2011 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxi, 968 p. : |
| Other physical details |
col. ill. ; |
| Dimensions |
28 cm |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Rev. ed. of: Pharmacology and the nursing process / Linda Lane Lilley, Scott Harrington, Julie S. Snyder. 5th ed. c2007 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references (p. 906-921) and index |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 1. Pharmacology basics. 1. The nursing process and drug therapy : Overview of the nursing process ; Assessment ; Nursing diagnoses ; Planning ; Implementation ; Evaluation -- 2. Pharmacologic principles : Overview ; Pharmaceutics ; Pharmacokinetics ; Pharmacodynamics ; Pharmacotherapeutics ; Pharmacognosy ; Pharmacoeconomics ; Toxicology ; Conclusion -- 3. Life span considerations : Drug therapy during pregnancy ; Drug therapy during breast-feeding ; Considerations for neonatal and pediatric patients ; Considerations for elderly patients -- 4. Cultural, legal, and ethical considerations : Cultural considerations ; U.S. drug and related legislation ; New drug development ; Cultural, legal, and ethical considerations for nursing practice -- 5. Gene therapy and pharmacogenetics : Basic principles of genetic inheritance ; Discovery, structure, and function of DNA ; Gene therapy ; Pharmacogenetics and pharmacogenomics ; Application of genetic principles related to drug therapy and the nursing process -- Summary -- 6. Medication errors: preventing and responding : General impact of errors on patients ; Medication errors ; Psychosocial issues that contribute to errors ; Preventing, responding to, reporting, and documenting medication errors: a nursing perspective ; Other ethical issues ; Summary -- 7. Patient education and drug therapy : Assessment of learning needs related to drug therapy ; Nursing diagnoses related to learning needs and drug therapy ; Planning related to learning needs and drug therapy ; Implementation related to patient education and drug therapy ; Evaluation of patient learning related to drug therapy ; Summary -- 8. Over-the-counter drugs and herbal and dietary supplements : Over-the-counter drugs ; Herbals and dietary supplements -- 9. Substance abuse : Opioids ; Stimulants ; Depressants ; Alcohol ; Nicotine -- 10. Photo atlas of drug administration : Preparing for drug administration ; Enteral drugs ; Parenteral drugs ; Topical drugs -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 2. Drugs affecting the central nervous system. 11. Analgesic drugs : Treatment of pain in special situations ; Opioid drugs ; Nonopioid and miscellaneous analgesics -- 12. General and local anesthetics : General anesthetics ; Drugs for moderate sedation ; Local anesthetics ; Neuromuscular blocking drugs -- 13. Central nervous system depressants and muscle relaxants : Physiology of sleep ; Benzodiazepines and miscellaneous hypnotic drugs ; Barbituates ; Muscle relaxants -- 14. Central nervous system stimulants and related drugs : Attention deficit hyperactivity disorder ; Narcolepsy ; Drugs for attention deficit hyperactivity and narcolepsy ; Obesity ; Migraine ; Analeptic-responsive respiratory depression syndromes ; Drugs for attention deficit hyperactivity disorder and narcolepsy ; Anorexiants ; Antimigraine drugs ; Drugs for specific respiratory depression syndromes: analeptics -- 15. Antiepiletic drugs : Epilepsy ; Antiepileptic drugs -- 16. Antiparkinsonian drugs : Parkinson's disease ; Indirect-acting dopaminergic drugs ; Monoamine oxidase inhibitors ; Presynaptic dopamine release enhancer ; Catechol ortho-methyltransferase inhibitors ; Direct-acting dopamine receptor agonists ; Nondopamine dopamine receptor agonists ; Dopamine replacement drugs ; Anticholinergic drugs -- 17. Psychotherapeutic drugs : Anxiolytic drugs ; Drugs used to treat affective disorders ; Mood-stabilizing drugs ; Antidepressant drugs ; Tricyclic antidepressants ; Monoamine oxidase inhibitors ; Newer generation antidepressants ; Antipsychotic drugs -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 3. Drugs affecting the autonomic nervous system. 18. Adrenergic drugs : Sympathetic nervous system ; Adrenergic drugs -- 19. Adrenergic- blocking drugs : Alpha-blockers ; Beta-blockers -- 20. Cholinergic drugs : Parasympathetic nervous system ; Cholinergic drugs -- 21. Cholinergic-blocking drugs : Parasympathetic nervous system ; Cholinergic-blocking drugs -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 4. Drugs affecting the cardiovascular and renal systems. 22. Heart failure drugs : Angiotensin-converting enzyme inhibitors ; Angiotensin II receptor blockers ; Beta-blockers ; Miscellaneous heart failure drugs ; B-type natriuretic peptide ; Phosphodiesterase inhibitors ; Cardiac glycosides -- 23. Antidysrhythmic drugs : Dysrhythmias and normal cardiac electrophysiology ; Antidysrhythmic drugs -- 24. Antianginal drugs : Nitrates and nitrites ; Beta-blockers ; Calcium channel blockers ; Miscellanous antianginal drug ; Summary of antianginal pharmacology -- 25. Antihypertensive drugs : Hypertension ; Review of autonomic neurotransmission ; Adrenergic drugs ; Angiotensin-converting enzyme inhibitors ; Angiotensin II receptor blockers ; Calcium channel blockers ; Diuretics ; Vasodilators ; Miscellaneous antihypertensive drugs -- 26. Diuretic drugs : Carbonic anhydrase inhibitors ; Loop diuretics ; Osmotic diuretics ; Potassium-sparing diuretics ; Thiazides and thiazide-like diuretics -- 27. Fluids and electrolytes : Crystalloids ; Colloids ; Blood products ; Potassium ; Sodium -- 28. Coagulation modifier drugs : Anticoagulants ; Antiplatelet drugs ; Antifibrilnolytic drugs ; Thrombolytic drugs -- 29. Antilipemic drugs : Lipids and lipid abnormalities ; Atherosclerotic plaque formation ; Link between cholesterol and coronary heart disease ; Hyperlipidemias and treatment guidelines ; Hydroxymethylglutaryl-coenzyme A reductase inhibitors ; Bile acid sequestrants ; Niacin ; Fibric acid derivatives and cholesterol absorption inhibitor -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 5. Drugs affecting the endocrine system. 30. Pituitary drugs : Endocrine system ; Pituitary drugs -- 31. Thyroid and antithyroid drugs : Thyroid function ; Hypothyroidism ; Thyroid replacement drugs ; Hyperthyroidism ; Antithyroid drugs -- 32. Antidiabetic drugs : Pancreas ; Diabetes mellitus ; Antidiabetic drugs ; Insulins ; Traditional oral drugs for diabetes ; Biguanide ; Sulfonylureas ; Glinides ; Thiazolidinediones ; Alpha-glucosidase inhibitors ; New antidiabetic drugs ; Amylin mimetics ; Incretin mimetics ; Hypoglycemia ; Glucose-elevating drugs -- 33. Adrenal drugs : Adrenal system ; Adrenal drugs -- 34. Women's health drugs : female reproductive functions ; Female sex hormones ; Estrogens ; Progestins ; Contraceptive drugs ; Drugs for osteoporosis ; Drugs related to pregnancy, labor, delivery and the postpartum period ; Fertility drugs ; Uterine stimulants -- 35. Men's health drugs : Male reproductive system ; Androgens and other drugs pertaining to men's health -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 6. Drugs affecting the respiratory system. 36. Antihistamines, decongestants, antitussives, and expectorants : Antihistamines ; Decongestants ; Antitussives ; Expectorants -- 37. Bronchodilators and other respiratory drugs : Diseases of the respiratory system ; Treatment of diseases of the lower respiratory tract ; Bronchodilators ; Beta-adrenergic agonists ; Anticholinergics ; Xanthine derivatives ; Nonbronchodilating respiratory drugs ; Leukotriene receptor antagonists ; Corticosteroids ; Monoclonal antibody antiasthmatic -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 7. Antiinfective and antiinflammatory drugs. 38. Antibiotics part 1 : Microbial infection ; Antibiotics ; Sulfonamides ; Beta-lactam antibiotics ; Penicillins ; Cephalosporins ; Carbapenems ; Monobactams ; Macrolides ; Ketolides ; Tetracyclines -- 39. Antibiotics part 2 : Multidrug resistance ; Aminoglycosides ; Quinolones ; Miscellaneous antibiotics -- 40. Antiviral drugs : General principles of virology ; Overview of viral illnesses and their treatment ; Herpes simplex virus and varicella-zoster virus infections ; Pharmacology overview of antivirals (non-HIV) ; Disease overview of HIV infection and AIDS ; Pharmacology overview of drugs used to treat HIV infection ; Disease overview of other viral infections -- 41. Antitubercular drugs : Tuberculosis ; Antitubercular drugs -- 42. Antifungal drugs : Fungal infections ; Antifungal drugs -- 43. Antimalarial, antiprotozoal, and anthelmintic drugs : Malaria ; Antimalarial drugs ; Other protozoal infections ; Antiprotozoal drugs ; Helminthic infections ; Anthelmintic drugs -- 44. antiinflammatory and antigout drugs : Nonsteroidal antiinflammatory drugs ; Antigout drugs -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 8. Immune and biologic modifiers and chemotherapeutic drugs. 45. Immunosuppressant drugs : Immune system ; Immunosuppressant drugs -- 46. Immunizing drugs and biochemical terrorism : Immunity and immunization ; Immunizing drugs ; Anthrax -- 47. Antineoplastic drugs part 1: cancer overview and cell cycle-specific drugs : Etiology of cancer ; Cancer drug nomenclature ; Drug therapy ; Cell cycle-specific antineoplastic drugs ; Antimetabolites ; Miotic inhibitors ; Alkaloid topoisomerase II inhibitors ; Topoisomerase I inhibitors ; Antineoplastic enzymes -- 48. Antineoplastic drugs part 2: cell cycle-nonspecific drugs and miscellaneous drugs : Cell cycle-nonspecific antineoplastic drugs ; Alkylating drugs ; Cytotoxic antibiotics ; Miscellaneous antineoplastics ; Hormonal antineoplastics ; Radiopharmaceuticals and related antineoplastics ; Cytoprotective drugs and miscellaneous toxicity inhibitors -- 49. Biologic response-modifying and antirheumatoid drugs : Overview of immunodulators ; Immune system ; Hematopoietic drugs ; Interferons ; Monoclonal antibodies ; Interleukins and related drugs ; Miscellaneous immunomodulating drugs ; Disease-modifying antirheumatoid arthritis drugs -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 9. Drugs affecting the gastrointestinal system and nutrition. 50. Acid-controlling drugs : Acid-related pathophysiology ; Antacids ; H₂ receptor antagonists ; Proton pump inhibitors ; Miscellaneous acid-controlling drugs -- 51. Bowel disorder drugs : Antidiarrheals ; Laxatives ; Drugs for irritable bowel syndrome -- 52. Antiemetic and antinausea drugs : Nausea and vomiting ; Antiemetic drugs -- 53. Vitamins and minerals : Vitamins ; Fat-soluble vitamins ; Vitamin A ; Vitamin D ; Vitamin E ; Vitamin K ; Water-soluble vitamins ; Vitamin B₁ ; Vitamin B₂ ; Vitamin B₃ ; Vitamin B₆ ; Vitamin B₁₂ ; Vitamin C ; Minerals ; Calcium ; Magnesium ; Phosphorus ; Zinc -- 54. Nutritional supplements : Enteral nutrition ; Parenteral nutrition ; Peripheral total parenteral nutrition ; Trace elements ; Central total parenteral nutrition -- |
| 505 2# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. 10. Miscellaneous therapeutics: hematologic, dermatologic, ophthalmic, and otic drugs. 55. Anemia drugs : Erythropoiesis ; Types of anemia ; Iron ; Folic acid ; Other anemia drugs -- 56. Dermatologic drugs : Antimicrobials ; General antibacterial drugs ; Antiacne drugs ; Antifungal drugs ; Antiviral drugs ; Anesthetic, antipruritic, and antipsoriatic drugs ; Topical anesthetics ; Topical antipruritics and antiinflammatories ; Antipsoriatic drugs ; Miscellaneous dermatologic drugs ; Wound care drugs ; Skin preparation drugs -- 57. Ophthalmic drugs : Lacrimal glands ; Layers of the eye ; Antiglaucoma drugs ; Cholinergic drugs ; Sympathomimetics ; Beta-adrenergic blockers ; Carbonic anhydrase inhibitors ; Osmotic diuretics ; Prostaglandin agonists ; Antimicrobial drugs ; Antiinflammatory drugs ; Topical anesthetics ; Diagnostic drugs ; Antiallergic drugs -- 58. Otic drugs : Treatment of ear disorders ; Antibacterial and antifungal otic drugs -- Appendix : Pharmaceutical abbreviations |
| 520 1# - SUMMARY, ETC. |
|---|
| Summary, etc. |
"This market-leading text is known for presenting challenging content in a clear and consistent format that is engaging and readable. With an eye-catching design, full-color illustrations, and helpful, practical boxed features that highlight need-to-know information, the new edition of this bestseller continues its tradition of making pharmacology easy to learn and understand."--BOOK JACKET |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| 9 (RLIN) |
2841 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Nursing |
| 9 (RLIN) |
2889 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lilley, Linda Lane |
| 9 (RLIN) |
5755 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Savoca, Diane |
| 9 (RLIN) |
5756 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lilley, Linda Lane. |
| Title of a work |
Pharmacology and the nursing process |
| 9 (RLIN) |
5757 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |